Article

Concurrent Autoimmune Diseases in MS

Is routine autoantibody testing beneficial in CIS?


 

References

Testing for autoantibodies during clinical work-up of patients with clinically isolated syndrome (CIS) should not be routinely performed, except when patients present with symptoms suggestive of other autoimmune diseases (AD), a prospective cohort study suggests.

Researchers followed 772 CIS patients who were tested for anti-nuclear-antibodies, anti-SSA and anti-SSB autoantibodies within the first year of diagnosis, and during a mean 6.6 years follow-up, found:

• One or more autoantibodies were present in 29% of patients.

• Only 1.8% of patients developed another AD.

• The concurrent AD was not considered the cause of CIS in any cases.

• In each case, the diagnosis of another AD was based on the symptoms suggested of the other disease.

Citation: Negrotto L, Tur C, Tintoré M, et al. Should we systematically test patients with clinically isolated syndrome for auto-antibodies? Mult Scler. 2015. doi:10.1177/1352458515575338.

Recommended Reading

Experimental MS Drug May Repair Nerve Damage
MDedge Neurology
Can Coffee Reduce the Risk of MS?
MDedge Neurology
What Happens When Patients With MS Stop Taking Their Medication?
MDedge Neurology
Epilepsy Drug May Preserve Eyesight for Patients With MS
MDedge Neurology
Tips for Coping With Multiple Sclerosis
MDedge Neurology
Switch to Oral Fingolimod May Improve MS Outcomes
MDedge Neurology
Conference News Update—Federation of American Societies for Experimental Biology
MDedge Neurology
Can FLAIR MRI Show Treatment Efficacy?
MDedge Neurology
Using the GAD-7 Scale in Multiple Sclerosis Patients
MDedge Neurology
Robert Fox, MD
MDedge Neurology